141 related articles for article (PubMed ID: 20446883)
1. Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
Höfer P; Friedrich F; Vyssoki B; Spindelegger C; Schmook M; Barnas C; Lesch OM; Walter H
World J Biol Psychiatry; 2010 Aug; 11(5):759-61. PubMed ID: 20446883
[No Abstract] [Full Text] [Related]
2. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
[No Abstract] [Full Text] [Related]
4. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
6. Effect of risperidone on prolactinoma--a case report.
Mendhekar DN; Jiloha RC; Srivastava PK
Pharmacopsychiatry; 2004 Jan; 37(1):41-2. PubMed ID: 14750048
[TBL] [Abstract][Full Text] [Related]
7. A possible effect of amisulpride on a prolactinoma growth in a woman with borderline personality disorder.
Perroud N; Huguelet P
Pharmacol Res; 2004 Sep; 50(3):377-9. PubMed ID: 15225684
[TBL] [Abstract][Full Text] [Related]
8. Hormonal imbalance and pituitary adenoma during antipsychotic treatment in an adolescent with bipolar affective disorder.
Rad F; Buica AM; Anghel GC; Stancu M; Dobrescu I
Riv Psichiatr; 2019; 54(1):37-39. PubMed ID: 30760936
[TBL] [Abstract][Full Text] [Related]
9. [Prolactinoma after craniocerebral trauma].
Schultz AM; Huber JC
Geburtshilfe Frauenheilkd; 1993 Sep; 53(9):641-2. PubMed ID: 8224725
[TBL] [Abstract][Full Text] [Related]
10. Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
Tschoner A; Engl J; Rettenbacher MA; Kaser S; Ott HW; Fleischhacker WW; Patsch JR; Ebenbichler CF
J Clin Psychiatry; 2009 Feb; 70(2):293-4. PubMed ID: 19265646
[No Abstract] [Full Text] [Related]
11. Amisulpride-induced mania with interictal psychosis.
Bakhla AK; Goyal N; Nizamie SH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1572-3. PubMed ID: 19766159
[No Abstract] [Full Text] [Related]
12. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
[TBL] [Abstract][Full Text] [Related]
13. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
Cookson J; Hodgson R; Wildgust HJ
J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
[TBL] [Abstract][Full Text] [Related]
14. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
Jagadheesan K; Muirhead D
Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
[No Abstract] [Full Text] [Related]
15. Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.
Paulzen M; Gründer G
Int J Neuropsychopharmacol; 2007 Feb; 10(1):149-51. PubMed ID: 16942633
[No Abstract] [Full Text] [Related]
16. [Some issues in the diagnosis and treatment of hyperprolactinemia].
Jin ZM
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
[No Abstract] [Full Text] [Related]
17. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Fric M; Laux G
Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D
Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388
[No Abstract] [Full Text] [Related]
19. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.
Kopecek M; Bares M; Horácek J
Neuro Endocrinol Lett; 2005 Aug; 26(4):320. PubMed ID: 16136015
[No Abstract] [Full Text] [Related]
20. [The value of functional tests in diagnosis of prolactinoma].
Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
